Fujian Acetron New Materials (300706) Fundamentals 2026 — Revenue Analysis | SniperIQ
Fujian Acetron New Materials (300706) is a CN-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥7.6B, trading at ¥49.69 on the SHZ. This SniperIQ fundamentals page covers Fujian Acetron New Materials's valuation, profitability (net margin -2.2%), revenue (¥1.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Fujian Acetron New Materials's market cap?
Fujian Acetron New Materials (300706) has a market capitalization of approximately ¥7.6B, trading at ¥49.69 on the SHZ. Market cap moves with the live share price.
What is Fujian Acetron New Materials's P/E ratio?
Fujian Acetron New Materials's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 11.0x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Fujian Acetron New Materials?
Fujian Acetron New Materials runs a net profit margin of -2.2%, a gross margin of 8.3%, and an operating margin of -3.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Fujian Acetron New Materials generate?
Fujian Acetron New Materials reported revenue of ¥1.4B for fiscal year 2025, with net income of -¥55M and earnings per share (EPS) of -0.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Fujian Acetron New Materials pay a dividend?
Fujian Acetron New Materials does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Fujian Acetron New Materials financially healthy?
Fujian Acetron New Materials carries a debt-to-equity ratio of 1.43x and a current ratio of 1.13x, with a market beta of 0.88. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Fujian Acetron New Materials a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Fujian Acetron New Materials (300706) the key facts are: market cap ¥7.6B, revenue ¥1.4B, 52-week range 25.51-93.9. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Fujian Acetron New Materials's full fundamentals live
Get Fujian Acetron New Materials's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.